GAD antibodies are associated with various neurological diseases including stiff person spectrum disorders (SPSD), cerebellar ataxia, PERM, LE, epilepsy, down beat nystagmus, autoimmune-related retinopathy and optic neuropathy (ARRON syndrome) (57–59). This evidence concerns the gene GAD1 and aceruloplasminemia.